Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 244

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 10
Chunk 244
---
Item 10. Additional Information.

A. Share Capital.

Not applicable.

B. Memorandum and Articles of Association.

Listing

Our ADSs are listed on the Nasdaq Global Select Market under the symbol “ IPHA.” Our ordinary shares are listed on Euronext Paris under the symbol “ IPH.”

Transfer Agent and Registrar

The transfer agent and registrar for our ADSs is Citibank, N. A. Our share register for our ordinary shares is maintained by Société Générale Securities Services. The share register reflects only record owners of our ordinary shares. Holders of our ADSs are not treated as our shareholders and their names are therefore not entered in our share register. The depositary, the custodian or their nominees are the holder of the shares underlying our ADSs. Holders of our ADSs have a right to receive the ordinary shares underlying their ADSs. For discussion on our ADSs and ADS holder rights, please refer to Exhibit 2.3 “ Description of Securities” of this Annual Report.

Corporate Purpose (Article 4 of the Bylaws)

Our corporate purpose, directly or indirectly, in France or other countries is to:

• carry out, on our own behalf or on behalf of third parties, any research, development, studies and development of manufacturing or marketing procedures for pharmaceutical products;

• register or grant any patent or license directly or indirectly connected with our activity; and

• more generally, perform any operation of any kind, whether economic, legal, financial, civil or commercial, which may be directly or indirectly related to our corporate purpose or any similar, associated or complementary purpose.

Executive Board (Articles 14 to 16 of the Bylaws)

The Executive Board is responsible for our management and is composed of a minimum of two members and a maximum of seven members who perform their duties under the supervision of the Supervisory Board.

Members of the Executive Board

The members of the Executive Board are appointed or have their appointments renewed by the Supervisory Board. The members of the Executive Board must be individuals. They are not required to be shareholders. They may be French citizens or citizens of other countries. Members of the Executive Board cannot be members of the Supervisory Board.

The maximum age for being a member of the Executive Board is 70 years. If the age limitation is exceeded, the term of the exceeding member of the Executive Board expires during the General Meeting of the shareholders following the anniversary date.

The limitations on having an appointment concurrently with an appointment in another company are subject to the applicable legal and regulatory